- Title: Subtitle
- Patterns of durable response with intralesional talimogene laherparepvec (T-VEC): Results from a phase III trial in patients with stage IIIb-IV melanoma
- Creators
- Merrick I. Ross - The University of Texas MD Anderson Cancer CenterRobert Hans Ingemar Andtbacka - Huntsman Cancer InstituteIgor Puzanov - Vanderbilt UniversityMohammed M. Milhem - University of IowaFrances A. Collichio - University of North Carolina at Chapel HillKeith A. Delman - Emory UniversityR Dirk Noyes - University of UtahJonathan S. Zager - Moffitt Cancer CenterLee D. Cranmer - University of ArizonaLynn E. Spitler - Northern California Melanoma CenterEddy C. Hsueh - Saint Louis UniversityDavid W. Ollila - University of North Carolina at Chapel HillThomas Amatruda - Minnesota OncologyLisa Chen - AmgenJennifer L. Gansert - AmgenHoward L Kaufman - Rutgers, The State University of New Jersey
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.32(15_suppl), pp.9026-9026
- DOI
- 10.1200/jco.2014.32.15_suppl.9026
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2014
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984363172202771
Abstract
Patterns of durable response with intralesional talimogene laherparepvec (T-VEC): Results from a phase III trial in patients with stage IIIb-IV melanoma
Journal of clinical oncology, Vol.32(15_suppl), pp.9026-9026
05/20/2014
DOI: 10.1200/jco.2014.32.15_suppl.9026
Details
Metrics
11 Record Views